Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study

BACKGROUND: Mycoplasma pneumoniae (MP) pneumonia is a self-limiting disease, but some patients complain of progressive pneumonia, despite of appropriate antibiotic treatment. We aimed to introduce the role of immune-modulators (corticosteroid and/or intravenous immunoglobulin, IVIG) treatment for ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Youn, You-Sook, Lee, Sung-Churl, Rhim, Jung-Woo, Shin, Myung-Seok, Kang, Jin-Han, Lee, Kyung-Yil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285006/
https://www.ncbi.nlm.nih.gov/pubmed/25566403
http://dx.doi.org/10.3947/ic.2014.46.4.239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285006/
https://www.ncbi.nlm.nih.gov/pubmed/25566403
http://dx.doi.org/10.3947/ic.2014.46.4.239

Ejemplares similares